Chloropyramine, solution for injection, 20 mg/ml, 1 ml each;Papaverine, solution for injection, 20 mg/ml, 2 ml each;Diosmectite powder for oral suspension 3 g each;Aminocaproic acid, solution for infusions, 50 mg/ml, 100 ml each;Dexketoprofen solution for injection 25 mg/ml in 2 ml;Amantadine solution for infusion, 0.4 mg/ml;Papaverine, tablets, 10 mg each;Ambroxol syrup, 15 mg/5 ml 100 ml;Chloramphenicol/methyluracil ointment 7.5 mg/40 mg per 40 g;Ketoprofen powder for oral solution 80 mg in a
By: Natalia Shramko๐ UkraineClosed
Key Information
| Reference | GB-UA-2026-11-16-012108-a |
|---|
| Deadline | Nov 19, 2026 12:00 AM |
|---|
| Estimated Value | UAH 19,250,000.00 |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Ukraine |
|---|
| Address | 02125, Ukraine, Kyiv region, Kyiv city, Kyiv city, Alishera Navoi ave., 3 |
|---|
| Published | Nov 16, 2026 |
|---|
Description
Chloropyramine, solution for injection, 20 mg/ml, 1 ml each;Papaverine, solution for injection, 20 mg/ml, 2 ml each;Diosmectite powder for oral suspension 3 g each;Aminocaproic acid, solution for infu...
Full details are available after unlocking this tender.